Amgen (Argentina) Performance

AMGN Stock  ARS 18,000  50.00  0.28%   
Amgen has a performance score of 4 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.34, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Amgen are expected to decrease at a much lower rate. During the bear market, Amgen is likely to outperform the market. Amgen Inc right now shows a risk of 1.92%. Please confirm Amgen Inc semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and standard deviation , to decide if Amgen Inc will be following its price patterns.

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Amgen Inc are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Amgen may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
Quick Ratio0.86
Fifty Two Week Low360.50
Payout Ratio1.48%
Fifty Two Week High4,141.00
  

Amgen Relative Risk vs. Return Landscape

If you would invest  1,695,963  in Amgen Inc on November 23, 2025 and sell it today you would earn a total of  104,037  from holding Amgen Inc or generate 6.13% return on investment over 90 days. Amgen Inc is generating 0.1126% of daily returns and assumes 1.9232% volatility on return distribution over the 90 days horizon. Simply put, 17% of stocks are less volatile than Amgen, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Amgen is expected to generate 1.0 times less return on investment than the market. In addition to that, the company is 2.58 times more volatile than its market benchmark. It trades about 0.06 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.15 per unit of volatility.

Amgen Target Price Odds to finish over Current Price

The tendency of Amgen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 18,000 90 days 18,000 
about 6.54
Based on a normal probability distribution, the odds of Amgen to move above the current price in 90 days from now is about 6.54 (This Amgen Inc probability density function shows the probability of Amgen Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Amgen Inc has a beta of -0.34. This suggests as returns on the benchmark increase, returns on holding Amgen are expected to decrease at a much lower rate. During a bear market, however, Amgen Inc is likely to outperform the market. Additionally Amgen Inc has an alpha of 0.1555, implying that it can generate a 0.16 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Amgen Price Density   
       Price  

Predictive Modules for Amgen

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Amgen Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
17,99818,00018,002
Details
Intrinsic
Valuation
LowRealHigh
14,80814,81019,800
Details
Naive
Forecast
LowNextHigh
17,61017,61217,614
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
13,10418,17923,253
Details

Amgen Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Amgen is not an exception. The market had few large corrections towards the Amgen's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Amgen Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Amgen within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.16
β
Beta against Dow Jones-0.34
σ
Overall volatility
661.04
Ir
Information ratio 0.03

Amgen Fundamentals Growth

Amgen Stock prices reflect investors' perceptions of the future prospects and financial health of Amgen, and Amgen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Amgen Stock performance.

About Amgen Performance

By analyzing Amgen's fundamental ratios, stakeholders can gain valuable insights into Amgen's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Amgen has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Amgen has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. AMGEN INC operates under Drug ManufacturersGeneral classification in Argentina and is traded on Buenos-Aires Stock Exchange. It employs 24300 people.

Things to note about Amgen Inc performance evaluation

Checking the ongoing alerts about Amgen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Amgen Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Evaluating Amgen's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Amgen's stock performance include:
  • Analyzing Amgen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Amgen's stock is overvalued or undervalued compared to its peers.
  • Examining Amgen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Amgen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Amgen's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Amgen's stock. These opinions can provide insight into Amgen's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Amgen's stock performance is not an exact science, and many factors can impact Amgen's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Amgen Stock analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals